1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Pharmaceutical Contract Manufacturing Market - Trends and Forecasts (2016 - 2021)

Contract manufacturing market is witnessing a high growth, as the pharmaceutical companies are focusing more on R & D of the drugs rather than manufacturing the formulated drug to stay competitive in the market. The global pharmaceutical contract manufacturing market was valued at USD 58 billion in 2016 and is expected to reach USD 84 billion by 2021, at a CAGR of 6.4% over the forecast period.

Overview of the Current Pharmaceutical Contract Manufacturing Industry

Companies in the upstream industry are undergoing restructuring so as to focus more on R & D, while stringent regulations on the pharmaceutical industry are compelling the companies to outsource manufacturing of drugs to contract manufacturers and focus on their core business processes. Pharmaceutical companies are increasingly relying on contract manufacturing, research, and packaging services, to fulfill their basic needs and specialized competencies.

The market for global pharmaceutical contract manufacturing by type has been broadly segmented into -


Active pharmaceutical ingredient (API) manufacturing
Finished Dosage Formulation (FDF) development & manufacturing (sub-segmented further into solid dose formulation, liquid dose formulation & injectable dose formulation)
Secondary market


By dose formulation type, solid dose formulation constituted more than 40% of the overall pharmaceutical contract manufacturing market in the year 2014, attributing to lower costs of manufacturing, patent compliance and ease of maintenance. The segment is expected to grow at a CAGR of 3.66% over the forecast period, while injectable dose segment, will register highest CAGR of 12.37% over the next five years.

The global pharmaceutical contract manufacturing market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

In 2014, the United States was a major market for contract pharmaceutical manufacturing.  India is estimated to be the fastest growing market owing to its cost competitiveness and quality manufacturing capabilities.

Factors driving the Pharmaceutical Market-


Growing innovative drugs
Increasing investments in R & D  
Pharmaceutical companies opting for less number of vendors to avail the volume advantage and at the same time reduce logistics costs.
Need for minimizing costs and reducing the product development time, without compromising on efficiency or production capability.




RESTRAINTS of the Pharmaceutical Market-

Some of the key impediments hindering the growth of the market are -


In-house packaging
Capacity utilization issues affecting the profitability of contract manufacturing organizations (CMOs)
Increasing lead time & logistics costs    


Opportunities of the Pharmaceutical Market-

Huge  demand for next-generation biological therapies  has opened a gateway of opportunities for pharmaceutical vendors/manufacturers across the globe.

Some of the  major companies  mentioned in the report are -


Aenova
Catalent
Famar
Haupt Pharma
Jubilant
Pfizer Central Source
Recipharm
Vetter  




Key Deliverables in the Study


Market analysis for the global pharmaceutical contract manufacturing market, with region specific assessments and competition analysis on global and regional scales.
Market definition along with the identification of key

DRIVERS and

RESTRAINTS.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the global pharmaceutical contract manufacturing market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insight about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights into the major countries/regions  where this industry is growing and also identify the regions that are still untapped.

Table Of Contents

Global Pharmaceutical Contract Manufacturing Market - Trends and Forecasts (2016 - 2021)
1. Introduction

                              1.1 Study Deliverables

                              1.2 Key Findings of the Study

                              1.3 Market Defnition

2. Research Methodology

3. Executive Summary

4. Market Dynamics

                              4.1 Current Market Trends

                              4.2 Drivers

                                                              4.2.1 Growing Innovative drugs

                                                              4.2.2 Increasing Investments in RandD

                              4.3 Restraints

                                                              4.3.1 In-house packaging

                                                              4.3.2 Capacity Utilization Issues Affecting the Profitability of CMOs

                                                              4.3.3 Increasing Lead Time and Logistics Costs

                              4.4 Maret Opportunities

                                                              4.4.1 Huge Demand for Next Generation Bilogical Surgeries

                              4.5 Porters Five Force Analysis

                                                              4.5.1 Threat of New Entrants

                                                              4.5.2 Bargaining Power of Consumers

                                                              4.5.3 Bargaining Power of Suppliers

                                                              4.5.4 Threat of Substitute Products and Services

                                                              4.5.5 Intensity of Competitive Rivalry

5. Global Pharma CMO Market Segmentation

                              5.1 By Liquid/Injectable

                                                              5.1.1 Solutions/Drops

                                                              5.1.2 Syrups

                                                              5.1.3 Tinctures

                                                              5.1.4 Suspensions

                                                              5.1.5 Elixirs

                                                              5.1.6 Emulsions

                                                              5.1.7 Concentrates

                              5.2 By Semi-Solid Dosage

                                                              5.2.1 Ointments

                                                              5.2.2 Creams

                                                              5.2.3 Pastes

                                                              5.2.4 Gels

                              5.3 By Gaseous Dosage

                                                              5.3.1 Aerosols

                                                              5.3.2 Inhalants

                                                              5.3.3 Sprays

                              5.4 By Dosage Forms by USP

                                                              5.4.1 Oral Drugs

                                                              5.4.2 Injectable/Parenteral

                                                              5.4.3 Topical/Transdermal

                                                              5.4.4 Inhaled Drugs

                                                              5.4.5 Mucosal Drugs

                              5.5 By Region

                                                              5.5.1 North America

                                                                                              5.5.1.1 U.S.

                                                                                              5.5.1.2 Canada

                                                                                              5.5.1.3 Rest Of North America

                                                              5.5.2 Europe

                                                                                              5.5.2.1 U.K

                                                                                              5.5.2.2 France

                                                                                              5.5.2.3 Germany

                                                                                              5.5.2.4 Russia

                                                                                              5.5.2.5 Rest of Europe

                                                              5.5.3 Asia-Pacific

                                                                                              5.5.3.1 China

                                                                                              5.5.3.2 Japan

                                                                                              5.5.3.3 India

                                                                                              5.5.3.4 Rest of Asia-Pacific

                                                              5.5.4 Latin America

                                                                                              5.5.4.1 Brazil

                                                                                              5.5.4.2 Argentina

                                                                                              5.5.4.3 Mexico

                                                                                              5.5.4.4 Rest of Latin America

                                                              5.5.5 Middle East and Africa

                                                                                              5.5.5.1 Saudi Arabia

                                                                                              5.5.5.2 UAE

                                                                                              5.5.5.3 Iran

                                                                                              5.5.5.4 South Africa

                                                                                              5.5.5.5 Rest of Middle East and Africa

6. Vendor Market Share Analysis

                              6.1 Pharmaceutical CMO Vendor Market Share

                              6.2 API Outsourcing Vendor Market Share (Top 10 Market Players)

7. Competitive Intelligence - Company Profiles

                              7.1 Catalent

                              7.2 Recipharm

                              7.3 Jubilant

                              7.4 Patheon

                              7.5 Vetter

                              7.6 Boehringer Ingelheim

                              7.7 Pfizer CentreSource

                              7.8 Aenova (Haupt)

                              7.9 Famar

                              7.10 Baxter Bio Pharma Solutions

                              7.11 Lonza

                              7.12 Biomeva

                              7.13 Fareva

8. Investment Analysis

                              8.1 Recent Mergers and Acquisitions

                              8.2 Investment Scenario and Opportunities

9. Future of Pharmaceutical Contract Manufacturing Market

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.